CTSO 8-K: Secondary offering

CytoSorbents

Filed with the SEC on · accession 0001104659-26-130442

CTSO filed a 8-K (current report) with the SEC on Nov 20, 2026. CytoSorbents entered into securities purchase agreements to sell approximately 556,681 common shares at $4.94/share plus pre-funded warrants for 151,822 shares, raising gross proceeds of approximately $4.0 million. The stock moved -6.4% by the first close after the filing.

Summary of the filing

CytoSorbents entered into securities purchase agreements to sell approximately 556,681 common shares at $4.94/share plus pre-funded warrants for 151,822 shares, raising gross proceeds of approximately $4.0 million. Net proceeds of ~$3.5 million will be used to repay $3.0 million of Avenue loan principal plus fees, with the remainder for general corporate purposes.

Key details

Gross proceeds from offering$4.0M
Net proceeds from offering$3.5M
Common shares sold to investorsshares 557K
Common shares sold to directors and officersshares 97K
Pre-funded warrants issuedshares 152K
Purchase price per common share$5
Purchase price per share to directors/officers$5
Avenue loan principal repayment$3.0M
Prepayment fee$53K
Final payment$270K
Financial advisory fee to WBB$30K
IssuerCytoSorbents Corporation
Exclusive placement agentH.C. Wainwright & Co., LLC
Financial advisorWBB Securities, LLC
Lender being repaidAvenue

How CTSO stock reacted

Close before

$5.13

Nov 19, 2026

First close after

-6.43%

$4.80

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CTSO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CTSO?

Click here

Frequently asked questions

What did CTSO file with the SEC on Nov 20, 2026?

CTSO filed a 8-K (Secondary offering). CytoSorbents entered into securities purchase agreements to sell approximately 556,681 common shares at $4.94/share plus pre-funded warrants for 151,822 shares, raising gross proceeds of approximately $4.0 million. Net proceeds of ~$3.5 million will be used to repay $3.0 million of Avenue loan principal plus fees, with the remainder for general corporate purposes.

What does a secondary offering mean for CTSO stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did CTSO stock react to this filing?

CTSO closed at $5.13 before the filing and $4.80 on Nov 20, 2026 (-6.43%).

Other CTSO SEC filings

Get alerts when CTSO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days